LIC MF Healthcare Fund Direct Growth

Equity
Direct
Sector - Healthcare
LIC MF Healthcare Fund Direct Growth

About the Fund

LIC MF Healthcare Fund Direct Growth is an equity fund. This fund was started on 28 February, 2019. The fund is managed by Karan Doshi. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. LIC MF Healthcare Fund Direct Growth has ₹60 Cr worth of assets under management (AUM) as on Jun 2024 and is less than category average.
  2. The fund has an expense ratio 1.2.

Returns

LIC MF Healthcare Fund Direct Growth has given a CAGR return of 20.96% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 44.27%, 11.45% and 23.10% respectively.

Holdings

LIC MF Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Piramal Pharma Ltd, J.B. Chemicals & Pharmaceuticals Ltd, Glenmark Pharmaceuticals Ltd, Cipla Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 15%
For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefit
Dividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.

Investment objective of LIC MF Healthcare Fund Direct Growth

The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 1000.00. LIC MF Healthcare Fund Direct Growth has no lock in period.

Fund Performance
zero opening, trading, fund transfer fee
13 people have invested ₹ 3.2L in LIC MF Healthcare Fund Direct Growth in the last three months

INDmoney Rank

Powered by IND quant engine
IND ranking is not available for this fund.
img
Beats FD returns for both 3Y & 5Y duration
img
5Y returns in the bottom 25% of the category
img
3Y returns in the bottom 25% of the category

Fund Overview

Expense ratio1.21%
Benchmark
S&P BSE Healthcare PR
AUM₹60 Cr
Inception Date28 February, 2019
Min Lumpsum/SIP₹5000/₹1000
Exit Load
1%
Lock InNo Lock-in
TurnOver
414.8%
Risk
Risk meter
pointer
Very High Risk

Fund Distribution
as on (30-Jun-24)

  • Equity 97.9%

  • Debt & Cash 2.1%

Large cap
42.1%

Small cap
31%

Mid cap
24.8%

Sector Allocation

May'24

Apr'24

Mar'24

Health
97.6%
Basic Materials
2.4%
All changes are between Apr'24 and Jun'24

Returns for the month of Jun

  • Gainers

  • Losers

Karan Doshi
Karan Doshi
Fund Manager of LIC MF Healthcare Fund Direct Growth, since 31 July 2023

Mutual Fund Insights

Insights icon
In the last 3 years, ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth has given 18.89% return, outperforming this fund by 7.44% per annum.
Insights icon
Over the last 1 month, this fund has experienced a 3.0% drop in AUM moving from 62.26 Cr to 60.38 Cr.
Insights icon
In the last 1 year, ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth has given 54.37% return, outperforming this fund by 10.1%.
Insights icon
This fund has one of the lowest expense ratio in the category (sector - healthcare). Its expense ratio is 1.21% which is lower than the category average expense ratio of 1.42%.
Insights icon
In the last 5 years, DSP Healthcare Fund Direct Growth has given 31.04% return, outperforming this fund by 7.94% per annum.

LIC MF Healthcare Fund Direct Growth Highlights

Risk meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 20.96% since inception which is less than its category average return of 23.03%
Fund Allocations

Fund Allocations

This fund has an allocation of 97.92% in Equity, 0% in Debt and 2.08% in Cash related instruments
AUM size ₹60 Cr

AUM size ₹60 Cr

This fund has AUM of ₹60 Cr which is less than its category average of ₹ 1735 Cr
Expense Ratio 1.21%

Expense Ratio 1.21%

This fund has an expense ratio of 1.21% which is less than its category average expense ratio of 1.45%

Frequently Asked Questions

The current NAV of LIC MF Healthcare Fund Direct Growth is ₹27.75 as on 12-Jul-2024.
Existing (Absolute + CAGR) as on 12-Jul-2024.
LIC MF Healthcare Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
4.3%
4.3%
6 Month Returns
17.61%
17.61%
1 Year Returns
44.27%
44.27%
3 Years Returns
38.44%
11.45%
5 Years Returns
182.66%
23.1%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
1.21% as on June 2024
₹60 Cr as on June 2024
Sun Pharmaceuticals Industries Ltd(11.37%), Piramal Pharma Ltd(6.25%), J.B. Chemicals & Pharmaceuticals Ltd(5.96%), Glenmark Pharmaceuticals Ltd(5.9%), Cipla Ltd(5.8%) as on June 2024
The alpha ratio for the LIC MF Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
LIC MF Healthcare Fund Direct Growth
0.61
-1.96
0.2
As on June 2024
The alpha for LIC MF Healthcare Fund Direct Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the LIC MF Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
LIC MF Healthcare Fund Direct Growth
0.9
0.91
0.9
As on June 2024
The Beta for LIC MF Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the LIC MF Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
LIC MF Healthcare Fund Direct Growth
2.03
0.38
0.92
As on June 2024
The sharpe ratio for LIC MF Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the LIC MF Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
LIC MF Healthcare Fund Direct Growth
14.04
14.28
17.9
As on June 2024
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 0.6 as on June 2024. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Karan Doshi is the fund manager of LIC MF Healthcare Fund Direct Growth
The Exit load of LIC MF Healthcare Fund Direct Growth is 1%